129 related articles for article (PubMed ID: 28940489)
1. Polymorphisms in homologous recombination repair genes and the risk and survival of breast cancer.
Liao YH; Ren JT; Zhang W; Zhang ZZ; Lin Y; Su FX; Jia WH; Tang LY; Ren ZF
J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28940489
[TBL] [Abstract][Full Text] [Related]
2. Modification Effects of Homologous Recombination Repair Gene Polymorphisms on the Associations Between Urinary Metals and Breast Cancer Risk.
Han S; Lu M; Zhang Y; Lin Y; Liu Q; Xu L; Ren Z
Biol Trace Elem Res; 2024 May; ():. PubMed ID: 38720017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
5. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-γ on breast cancer risk.
He JR; Chen LJ; Su Y; Cen YL; Tang LY; Yu DD; Chen WQ; Wang SM; Song EW; Ren ZF
J Infect Dis; 2012 Jan; 205(1):64-71. PubMed ID: 22095765
[TBL] [Abstract][Full Text] [Related]
6. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
7. Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy Cantonese.
Shen GP; Pan QH; Hong MH; Qin HD; Xu YF; Chen LZ; Feng QS; Jorgensen TJ; Shugart YY; Zeng YX; Jia WH
Int J Cancer; 2011 Sep; 129(6):1459-66. PubMed ID: 21792882
[TBL] [Abstract][Full Text] [Related]
8. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.
Zhu RM; Lin W; Zhang W; Ren JT; Su Y; He JR; Lin Y; Su FX; Xie XM; Tang LY; Ren ZF
PLoS One; 2017; 12(6):e0178850. PubMed ID: 28591216
[TBL] [Abstract][Full Text] [Related]
9. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer.
Zhang W; Zhang ZZ; Tang LY; Lin Y; Su FX; Xie XM; Su XF; Ren ZF
Tumour Biol; 2016 Jun; 37(6):8337-47. PubMed ID: 26729199
[TBL] [Abstract][Full Text] [Related]
11. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
12. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Harvey VJ; Neven P; Treilleux I; Rasmussen BB; Maibach R; Price KN; Coates AS; Goldhirsch A; Pagani O; Viale G; Rae JM; Regan MM
Breast Cancer Res Treat; 2015 Jun; 151(2):373-84. PubMed ID: 25935582
[TBL] [Abstract][Full Text] [Related]
13. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
[TBL] [Abstract][Full Text] [Related]
15. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
[TBL] [Abstract][Full Text] [Related]
16. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
17. [Association study of genetic variations in SLCO1B3 gene with prognosis in breast cancer patients treated with neoadjuvant chemotherapy of TA regimen].
Du ZL; Xu CS; Bian ZM; Peng MT; Li CB; Feng T; Xu XZ; Liu HJ; Zhang BL
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):587-593. PubMed ID: 31434449
[No Abstract] [Full Text] [Related]
18. Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer.
Lin W; Lin HD; Guo XY; Lin Y; Su FX; Jia WH; Tang LY; Zheng W; Long JR; Ren ZF
Mol Carcinog; 2017 Jan; 56(1):300-311. PubMed ID: 27128794
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
20. Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.
Chen H; Qi X; Qiu P; Zhao J
Int J Clin Exp Pathol; 2015; 8(5):5798-802. PubMed ID: 26191300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
